Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in Biodetection & Biosensors

Christopher Lowe's Biography

Christopher Lowe, Professor, University of Cambridge, Director, Cambridge Academy of Therapeutic Sciences

Professor Christopher R. Lowe was founder Director of the Institute of Biotechnology at the University of Cambridge and conducts research in both diagnostics and therapeutics in the healthcare biotechnology sector. He is a fellow of the Royal Academy of Engineering, the Institute of Physics and the Royal Society of Chemistry. He has 395 peer-reviewed publications, 8 books and monographs, >100 patents and has supervised >95 PhD students and has a number of national and international prizes: “Queen’s Award for Technological Achievement”; “Queen’s Anniversary Prize for Higher and Further Education”; “Most Entrepreneurial Scientist of the UK”; OBE in the Queen’s New Year Honours; BBSRC Commercial Innovator of the Year in 2011. He has been the driving force for the establishment of 11 spin-out companies including ProMetic Biosciences Inc (Market Cap $1.9-2.1B), Cambridge Sensors Ltd, Paramata Ltd, Psynova Neurotech Ltd and Royale Therapeutics Ltd., has a number of directorships and fosters entrepreneurship within the University via a Master’s in Bioscience Enterprise, the University’s Seed Fund Committee and other Business School and student-led activities. He is active in various government committees and in a number of legal and entrepreneurial roles. His group's primary research interest is in healthcare biotechnology, particularly where it is applied to the biopharmaceutical, sensors and diagnostics and enzyme and microbial technology sectors. The work is highly multidisciplinary and not only covers aspects of molecular biology, biochemistry, microbiology, chemistry, physics, electronics and engineering, but also the entire range from fundamental science to strategic and applied science. He is currently Director of the newly established Cambridge Academy of Therapeutic Sciences (CATS) within the University of Cambridge.

Christopher Lowe Image

Recent Advances in Biodetection

Tuesday, 11 March 2014 at 10:30

Add to Calendar ▼2014-03-11 10:30:002014-03-11 11:30:00Europe/LondonRecent Advances in BiodetectionAdvances in Biodetection and Biosensors in Berlin, GermanyBerlin,

The role of a biological detection capability is to acquire information on events and hazards to allow individuals and decision makers to manage risk, to indicate the presence of threats and hazards and, when and where required, classify, identify and quantify them. This presentation will review the biological challenge and the generic detection methodologies based on physical, chemical and biological properties that may be utilised to form an integrated biodetection system. Examples of optical, acoustic and microengineered technologies will be given.

Add to Calendar ▼2014-03-10 00:00:002014-03-11 00:00:00Europe/LondonAdvances in Biodetection and BiosensorsAdvances in Biodetection and Biosensors in Berlin, GermanyBerlin,